Upon tumour growth, Atrogin1 expression was enriched in specialized MTJ and NMJ myonuclei, which also exhibited distinctive changes in their transcriptomes, including increased Eda expression in MTJ and reduced Deptor and Nos1 expression in NMJ (Figure5C,D). This evidence concerns the gene FBXO32 and neoplasm.